Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carin Binder

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 25, 2004
Acceptability and disintegration rates of orally disintegrating risperidone tablets in patients with schizophrenia or schizoaffective disorderPierre Chue, Ron Welch, Carin Binder
Journal of Child and Adolescent Psychopharmacology|August 21, 2004
Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQMichael G Aman, Carin Binder, Atilla Turgay
Pediatrics|September 3, 2002
Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQsAtilla Turgay, Carin Binder, Richard Snyder, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 16, 2005
Galantamine treatment of problematic behavior in Alzheimer disease: post-hoc analysis of pooled data from three large trialsNathan Herrmann, Kiran Rabheru, Jenny Wang, et al.
Current Medical Research and Opinion|December 15, 2006
Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorderAngelo Fallu, Caroline Richard, Rosanna Prinzo, et al.
International Clinical Psychopharmacology|April 13, 2004
Risperidone plus lithium versus risperidone plus valproate in acute and continuation treatment of maniaLakshmi N Yatham, Carin Binder, Vivek Kusumakar, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 10, 2005
Open-label adjunctive topiramate in the treatment of unstable bipolar disorderRoger S McIntyre, Rosanna Riccardelli, Carin Binder, et al.
Headache|October 17, 2006
Topiramate prophylaxis and response to triptan treatment for acute migraineWerner J Becker, Suzanne N Christie, Stephane Ledoux, et al.
Drugs & Aging|June 26, 2009
Persistence with cholinesterase inhibitor therapy for dementia: an observational administrative health database studyNathan Herrmann, Carin Binder, William Dalziel, et al.
Journal of Child and Adolescent Psychopharmacology|May 25, 2005
Pharmacotherapy of disruptive behavior and item changes on a standardized rating scale: pooled analysis of risperidone effects in children with subaverage IQMichael Aman, Jan Buitelaar, Goedele De Smedt, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 25, 2004
Acceptability and disintegration rates of orally disintegrating risperidone tablets in patients with schizophrenia or schizoaffective disorderPierre Chue, Ron Welch, Carin Binder
Journal of Child and Adolescent Psychopharmacology|August 21, 2004
Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQMichael G Aman, Carin Binder, Atilla Turgay
Pediatrics|September 3, 2002
Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQsAtilla Turgay, Carin Binder, Richard Snyder, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 16, 2005
Galantamine treatment of problematic behavior in Alzheimer disease: post-hoc analysis of pooled data from three large trialsNathan Herrmann, Kiran Rabheru, Jenny Wang, et al.
Current Medical Research and Opinion|December 15, 2006
Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorderAngelo Fallu, Caroline Richard, Rosanna Prinzo, et al.
International Clinical Psychopharmacology|April 13, 2004
Risperidone plus lithium versus risperidone plus valproate in acute and continuation treatment of maniaLakshmi N Yatham, Carin Binder, Vivek Kusumakar, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 10, 2005
Open-label adjunctive topiramate in the treatment of unstable bipolar disorderRoger S McIntyre, Rosanna Riccardelli, Carin Binder, et al.
Headache|October 17, 2006
Topiramate prophylaxis and response to triptan treatment for acute migraineWerner J Becker, Suzanne N Christie, Stephane Ledoux, et al.
Drugs & Aging|June 26, 2009
Persistence with cholinesterase inhibitor therapy for dementia: an observational administrative health database studyNathan Herrmann, Carin Binder, William Dalziel, et al.
Journal of Child and Adolescent Psychopharmacology|May 25, 2005
Pharmacotherapy of disruptive behavior and item changes on a standardized rating scale: pooled analysis of risperidone effects in children with subaverage IQMichael Aman, Jan Buitelaar, Goedele De Smedt, et al.
Pageof 2